Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

3.930 -0.360 (-8.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
SciSparc Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand
From SciSparc Ltd
Via GlobeNewswire
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
From SciSparc Ltd
Via GlobeNewswire
SciSparc Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
From SciSparc Ltd
Via GlobeNewswire
Jeffs' Brands Joins Hand With SciSparc For New Line Of Products
 
Via Benzinga
Why Is SciSparc (SPRC) Stock Up 50% Today?
SPRC stock is catapulting higher this morning as traders catch wind of SciSparc's intent to acquire a top niche product seller on Amazon. 
Via InvestorPlace
SciSparc Enters Into Letter of Intent with an E-commerce Company to Establish a Joint Venture to Market and Develop a New Product Line
From SciSparc Ltd
Via GlobeNewswire
SciSparc Gains Competitive Edge with Additional U.S. Patent Granted
From SciSparc Ltd
Via GlobeNewswire
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system announced positive interim... 
Via Benzinga
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
From SciSparc Ltd
Via GlobeNewswire
Why FAT Brands Shares Are Trading Sharply Lower; Here Are 24 Stocks Moving Premarket
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares rose 39.5% to $24.39 in pre-market trading following recent reports that Donald Trump could soon announce 2024 Presidential run. 
Via Benzinga
SciSparc Nutraceuticals Signs Agreement With Logistics Facilities, Expected To Optimize Handling and Shipment Processes and Reduce Direct Sales Costs
SciSparc Ltd. (NASDAQ: SPRC) announced that SciSparc Nutraceuticals Inc., its wholly owned subsidiary, has signed an agreement with logistics facilities in New Jersey, U.S. as part of SciSparc... 
Via Benzinga
SciSparc: Wellution™ Signs an Agreement with Logistics Facilities in New Jersey to Supports its Expansion to Additional e-Commerce Platforms
From SciSparc Ltd
Via GlobeNewswire
SciSparc: Wellution™ Successfully Launched a New Keto Gummies Apple Cider Vinegar Product and Generated $100,000 In Revenues Within 30 Days
From SciSparc Ltd
Via GlobeNewswire
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
From SciSparc Ltd
Via GlobeNewswire
SciSparc Acquires Top Seller On Amazon, Wellution, For $20M
SciSparc Ltd. (NASDAQ: SPRC) closed the definitive agreements for its acquisition of Wellution, an Amazon.com Marketplace account, American food supplements and cosmetics brand and trademark. 
Via Benzinga
SciSparc Completes the Acquisition of Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
From SciSparc Ltd
Via GlobeNewswire
SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes
SciSparc Ltd. (NASDAQ: SPRC) announced that Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0), has filed a provisional patent application related to metabolic syndromes including obesity,... 
Via Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Dow, S&P 500 Turn Lower; Altimmune Shares Slide
U.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday. 
Via Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome... 
Via Benzinga
CFVI Stock Heats Up Ahead of Rumble SPAC Merger Vote
CF Acquisition (CFVI) stock is getting a boost on Wednesday as investors prepare to vote on a SPAC merger with Rumble tomorrow. 
Via InvestorPlace
Nasdaq Surges 100 Points; Crude Oil Rises 2%
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday. 
Via Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
Via Benzinga
SciSparc To Acquire Top Amazon Seller: Why SPRC Shares Are Soaring Today
SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company announced it entered into an agreement to acquire Wellution for $20 million. 
Via Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. 
Via Benzinga
SciSparc To Acquire One Of Top Sellers Of Food Supplements, Cosmetics And Hemp-Based Products On Amazon
SciSparc Ltd. (NASDAQ: SPRC) signed a definitive agreement with Merhavit M.R.M Holding and Management Ltd (“M.R.M”), to acquire its rights to purchase, Wellution, an Amazon.com (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 122 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 250 stocks hit new 52-week lows. 
Via Benzinga
Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration
SciSparc Ltd. (NASDAQ: SPRC) recently announced additional positive pre-clinical results of its Psychedelic-based Pharma Collaboration for treatment for cocaine addiction using MEAI, a novel... 
Via Benzinga
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
Results indicate significant decrease in cocaine craving in a sub-group that received the treatment 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.